Peter Bertinato | Researchain

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Peter Bertinato is active.

Explore More

Publication

Featured researches published by Peter Bertinato.

Bioorganic & Medicinal Chemistry Letters | 2003

Azalide 3,6-Ketals: antibacterial activity and structure–Activity relationships of aryl and hetero aryl substituted analogues

Subas M. Sakya; Peter Bertinato; Bryan Pratt; Melani Suarez-Contreras; Kristin Marie Lundy; Martha L. Minich; Hengmiao Cheng; Carl Bernard Ziegler; Barbara J. Kamicker; Shigeru F. Hayashi; Sheryl L. Santoro; David M. George; Camilla D. Bertsche

Aryl and hetero aryl substituted 3,6-ketals of 15-membered azalide analogues were synthesized and were found to have potent in vitro antibacterial activity against veterinary pathogens, including Staphylococcus aureus and Pasteurella multocida.

Archive | 2006

Triamide-substituted heterobicyclic compounds

Peter Bertinato; Michel Couturier; Ernest Seiichi Hamanaka; Marcus Ewing; Ralph P. Robinson; Derek L. Tickner

Archive | 2002

Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (MTP) and/or apolipoprotein b (APO B) secretion

Peter Bertinato; Alan Elwood Blize; Brian Scott Bronk; Hengmiao Cheng; Hiep Huatan; Jin Li; Clive Philip Mason

Archive | 1999

13-membered azalides and their use as antibiotic agents

Robert J. Rafka; Barry James Morton; Colman Brendan Ragan; Peter Bertinato; John P. Dirlam; Alan Elwood Blize; Carl Bernard Ziegler

Archive | 2005

Substituted quinoline compounds

Peter Bertinato; Michel Couturier; Ernest Seiichi Pfizer Global R D Hamanaka; Marcus Ewing; Ralph P. Robinson; Derek L. Tickner

Archive | 1999

C11 Carbamates of macrolide antibacterials

Hengmiao Cheng; Michael A. Letavic; Carl Bernard Ziegler; Jason K. Dutra; Peter Bertinato; Brian Scott Bronk

Bioorganic & Medicinal Chemistry Letters | 2007

In vitro and in vivo profile of 5-[(4' -trifluoromethyl -biphenyl -2-carbonyl ) -amino]-1H -indole -2 -carboxylic acid benzylmethyl carbamoylamide (dirlotapide), a novel potent MTP inhibitor for obesity

Jin Li; Brian Scott Bronk; John P. Dirlam; Alan Elwood Blize; Peter Bertinato; Burton H. Jaynes; Anne Hickman; Christine Pfizer Global Res And Dev E. Miskell; Usha A. Pillai; Jay S. Tibbitts; Michelle L. Haven; Nicole L. Kolosko; Chris J. Barry; Tara B. Manion

Bioorganic & Medicinal Chemistry Letters | 2006

Discovery of potent and orally active MTP inhibitors as potential anti-obesity agents

Jin Li; Peter Bertinato; Hengmiao Cheng; Bridget Mccarthy Cole; Brian Scott Bronk; Burton H. Jaynes; Anne Hickman; Michelle L. Haven; Nicole L. Kolosko; Chris J. Barry; Tara B. Manion

Nihon rinsho. Japanese journal of clinical medicine | 2003

Microsomal Triglyceride transfer protein inhibitor

Peter Bertinato; Brian Scott Bronk; Hengmiao Cheng; George Chang; Bridget Mccarthy Cole; Jin Li; Roger Benjamin Ruggeri

Bioorganic & Medicinal Chemistry Letters | 2011

Discovery of microsomal triglyceride transfer protein (MTP) inhibitors with potential for decreased active metabolite load compared to dirlotapide.

Ralph P. Robinson; Jeremy A. Bartlett; Peter Bertinato; Andrew J. Bessire; Judith M. Cosgrove; Patrick M. Foley; Tara B. Manion; Martha L. Minich; Brenda Ramos; Matthew R. Reese; Theodore J. Schmahai; Andrew G. Swick; David A. Tess; Alfin D. N. Vaz; Angela Wolford

Explore More